GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (LSE:ABC) » Definitions » Short Interest

Abcam (LSE:ABC) Short Interest


View and export this data going back to 2005. Start your Free Trial

What is Abcam Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Abcam's Short Interest

For the Biotechnology subindustry, Abcam's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abcam's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abcam's Short Interest distribution charts can be found below:

* The bar in red indicates where Abcam's Short Interest falls into.


Abcam (LSE:ABC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (LSE:ABC) » Definitions » Short Interest
Comparable Companies
ACAD CRSP HALO RVMD BPMC NUVL MDGL INSM PCVX FOLD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
N/A
Address
Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX
Website
https://www.abcam.com
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.

Abcam (LSE:ABC) Headlines

No Headlines